Senior Editor Peter Wehrwein speaks with Lou Ellen Horwitz, CEO of the Urgent Care Association, in this part two of two video series about centers that have not been paid yet for tests.
Urgent care centers are testing patients for COVID-19. But the reimbursement to the centers for that testing “is still kind of murky,” according to Lou Ellen Horwitz, CEO of the Urgent Care Association.
“I don’t know anyone who has actually gotten paid yet, so we are billing on hope that this going to be worked out because everybody says it is going to be worked — ‘we are committed to being part of the solution,’— etcetera, etcetera,”Horwitz said in a recent video interview with Managed Healthcare Executive
In follow-up email, Horwitz explained that urgent care centers are usually paid a capitated rate that covers the normal run of problems seen in urgent care, including tests for flu. But her members want payers to go beyond the usual capitated rate and reimburse for COVID-19 tests. Horwitz said that her members operate on a thin margin and without the additional reimbursement, every patient tested for COVID-19 may be a patient that costs the urgent care center money.
Horwitz said that it is unclear what role urgent care centers might play in administering a COVID-19 vaccine, if and when one becomes available. She noted that urgent centers are part of flu immunization protocols “and have been forever.”
“At least give us an opportunity to be part of that,” she said.
Horwitz, whose association represents about 4,500 urgent care centers, noted that urgent care centers don’t have the clout that hospitals and some other providers others. As a result, they have had to jockey for position in the COVID-19 response. Personal protective equipment and access to testing, especially the equipment for rapid tests, have sometimes been in short supply. Horwitz said urgent care centers are testing patients for COVID-19 but are, for the most, sending the samples out to labs rather than using the rapid-test machines.
Horwitz said patient volumes at urgent care centers were at record levels in July because of the combination of normal kind of problems seen at urgent care centers and the addition of COVID-19-related issues.
“I am not getting the sense of, ‘Oh my gosh, we are going to have close our doors.” That is how everybody felt the first week in April — ‘is anyone ever going to come back again?’”
The challenges now are more operational than financial, says Horwitz, as the urgent care centers owners and manager have to decide whether to add staff for the upcoming flu season and what might be a second wave of COVID-19.
Horwitz said there is a lot of discussion of a “four in one” test that would assess, more or less simultaneously, whether a patient has flu, strep throat, COVID-19 or respiratory syncytial virus (RSV). She noted that there will be a danger this fall and winter of assuming it is COVID-19 when other infections might be making people ill.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More